Heart Failure: A Clinical Nursing Handbook

Heart Failure: A Clinical Nursing Handbook

Volumn , Issue , 2008, Pages 1-258

  Nicholson, Christopher ^a  

^a Central Lancashire PCT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889791650     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470988107     Document Type: Book

References (349)

1. Abramson J L, Williams S A, Krumholz H M and Vaccarino V (2001) Moderate alcohol consumption and risk of heart failure amongst older persons. Journal of the American Medical Association 285 (15), pp. 1971-1977.
2. Ades P A (2001) Cardiac rehabilitation and secondary prevention of coronary heart disease. The New England Journal of Medicine 345 (12), pp. 892-902.
3. Ahmed A (2002) Quality and outcomes of heart failure care in older adults: role of multidisciplinary disease-management programs. Journal of the American Geriatrics Society 50 (9), pp. 1590-1593.
4. Ahmed A (2007) A propensity matched study of New York Heart Association Class and Natural History End Points in heart failure. American Journal of Cardiology 99 (4), pp. 549-553.
5. Ahmed A and Allman R M (2003) Alcohol and congestive heart failure. Letter. Annals of Internal Medicine 138 (1), p. 75.
6. Ahmed A, Sims R V, Allman R M, De Long J F and Aronow W S (2003) Racial variations in cardiology care among hospitalized older heart failure patients. Heart Disease 5 (1), pp. 8-14.
7. Ahmed A, Allman R A, Aronow W S and De Long J F (2004) Diagnosis of heart failure in older adults: predictive value of dyspnoea at rest. Archives of Gerontology and Geriatrics 38 (3), pp. 297-307.
8. Ahmed A, Husain A, Love T E, Gambasi G, Dellitalia L J, Francis G S et al. (2006) Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. European Heart Journal 27 (12), pp. 1431-1439.
9. Akashi Y J, Springer J and Anker S D (2005) Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches. Current Heart Failure Reports 2 (4), pp. 198-203.
10. Ali A, Mehra M R, Malik F S, Lavie C J, Bass D and Milani R V (1999) Effects of aerobic exercise training on indices of ventricular repolarisation in patients with chronic heart failure. Chest 116 (1), pp. 83-87.
11. Allan R, Kass M, Glover C and Haddad H (2007) Cellular transplantation: future therapeutic options. Current Opinion in Cardiology 22 (92), pp. 104-110.
12. Anand I S, MacMurray J J V, Whitmore J et al. (2005) Anaemia and clinical outcome in heart failure. Cardiology Review 22 (4), pp. 12-15.
13. Anderson C, Deepak B V, Amoateng-Adjepong Y and Zarich S (2005) Benefits of comprehensive inpatient education and discharge planning combined with outpatient support in elderly patients with congestive heart failure. Congestive Heart Failure 11 (6), pp. 315-321.
14. Anderson M K, Markenvard J D, Schjott H, Nielson H L and Gustafason F (2005) Effects of a nurse-based heart failure clinic on drug utilization and admissions in a community hospital setting. Scandinavian Cardiovascular Journal 39 (4), pp. 199-205.
15. Andrew P (2003) Diastolic heart failure demystified. Chest 124 (2), pp. 744-753.
16. Appleton B (2004) The role of exercise training in patients with chronic heart failure. British Journal of Nursing 13 (8), pp. 452-456.
17. Aquilar D, Skali H, Moye L A, Lewis E F, Gaziano J M, Rutherford J D et al. (2004) Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction. Journal of the American College of Cardiology 43 (11), pp. 2015-2021.
18. Austin J, Williams R, Linda R, Moseley L and Hutchinson S (2005) Randomised controlled trial of cardiac rehabilitation in elderly patients with heart failure. European Journal of Heart Failure 7 (3), pp. 411-417.
19. Azevedo C F, Cheng S and Lima J A (2005) Cardiac imaging to identify patients at risk for developing heart failure after myocardial infarction. Current Heart Failure Reports 2 (4), pp. 183-188.
20. Badgett R G, Lucey C R and Mulrow C D (1997) Can the clinical examination diagnose left-sided heart failure in adults? Journal of the American Medical Association 277 (21), pp. 1712-1719.
21. Baig M K, Mahon N, McKenna W J, Caforio A L P, Bonow R O, Francis G S et al. (1999) The pathophysiology of advanced heart failure. Heart and Lung 28 (2), pp. 87-97.
22. Bardy G H, Lee K L, Mark D B, Poole J E, Packer D L, Boineau R et al. (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. The New England Journal of Medicine 352 (20), pp. 225-237.
23. Barnes S, Gott M and Payne S (2006) Communication in heart failure: perspectives from older people and primary care professionals. Health & Social Care in the Community 14 (6), pp. 482-490.
24. Barry W L and Sarembock I J (1998) Cardiogenic shock: therapy and prevention. Clinical Cardiology 21 (2), pp. 72-80.
25. Bartenek J, Vanderheyden M, Wijns W, Timmermans F, Vanderkerkhove B, Villa A et al. (2007) Bone marrow derived cells for cardiac stem cell therapy: safe or still under scrutiny? Nature Clinical Practice. Cardiovascular Medicine 4 (S1), pp. 100-105.
26. Baxter A J, Spensley A, Hildreth A, Karimova G, O'Connell J E and Gray C S (2002) Beta-blockers in older persons with heart failure: tolerability and impact on quality of life. Heart 88 (6), pp. 611-614.
27. Bell D S H (2002) Diabetic cardiomyopathy: a unique entity or a complication of coronary artery disease? Diabetes Care 18 (5), pp. 708-714.
28. Bell D S H (2003) Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 26 (8), pp. 2433-2441.
29. Bellardinelli R, Georgiou D, Cianci G and Purcaro A (1999) Randomised controlled trial of long term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 99 (9), pp. 1173-1182.
30. Beniaminovitz A, Lang C C, LaManca J and Mancini D (2002) Selective low leg muscle training alleviates dyspnoea in patients with heart failure. Journal of the American College of Cardiology 40 (9), pp. 1602-1608.
31. Bertoni A G, Goff D C, D'Agnostino R B, Liu K, Hundley W G, Lima J A et al. (2006) Diabetic cardiomyopathy and sub clinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 29 (3), pp. 588-594.
32. Bessen H A (1986) Therapeutic and toxic effects of digitalis: William Withering, 1785. The Journal of Emergency Medicine 4 (3), pp. 243-248.
33. Blue L, Lang E, McMurray J J V, Davie A P, McDonagh T A, Murdoch D R et al. (2001) Randomised controlled trial of specialist nurse intervention in heart failure. British Medical Journal 323 (7315), pp. 715-718.
34. Bozkurt B and Deswal A (2005) Obesity as a prognostic factor in chronic symptomatic heart failure. American Heart Journal 150 (6), pp. 1233-1239.
35. British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, Stroke Association (2005) JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 91 Supplement 5, pp. v1-52.
36. Brophy J M, Joseph L and Rouleau J L (2001) Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Annals of Internal Medicine, 134, (7), pp. 550-560.
37. Bryson C L, Mukamal K J, MittlemanMA, Fried L P, Hirsch C H, Kitzman DWet al. (2006) The association of alcohol consumption and incident heart failure: the Cardiovascular Health Study. Journal of the American College of Cardiology 48 (2), pp. 305-311.
38. Buetow S A and Coster G D (2001) Do general practice patients with heart failure understand its nature and seriousness, and want improved information? Patient Education and Counseling 45 (3), pp. 181-185.
39. Buetow S A, Goodyear S F and Coster G (2001) Coping strategies in the self-management of chronic heart failure. Family Practice 18 (2), pp. 117-122.
40. Bungard T J, McAlister F A, Johnson J A and Tsuyuki R T (2001) Underutilisation of ACE inhibitors in patients with congestive heart failure. Drugs 61 (14), pp. 2021-2033.
41. Burian J, Buser P and Eriksson U (2005) Myocarditis: the immunologists view on pathogenesis and treatment. Swiss Medical Weekly 135 (25-26), pp. 359-364.
42. Buxton A E, Lee K L, Fisher J D, Josephson M E, Prystowsky E N and Hafley G (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. The New England Journal of Medicine 341 (25), pp. 1882-1890.
43. Caldwell M A, Peters K J and Dracup K S (2005) A simplified education program improves knowledge, self care behaviour, and disease severity in heart failure patients in rural settings. American Heart Journal 150 (5), pp. 983.
44. Calvert M J, Freemantle N, Yao G, Cleland J G F, Billingham L and Daubert J et al. (2005) Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial. European Heart Journal, 26 (24), pp. 681-688.
45. Chambers J, Fuat A, Liddiard S, McDonagh T, Monaghan M, Nihoyannopoulus P et al. (2004) Community echocardiography for heart failure: a consensus statement from representatives of the British Society of Echocardiography, the British Heart Failure Society, the Coronary Heart Disease Collaborative and the Primary Care Cardiovascular Society. British Journal of Cardiology 11 (5), pp. 399-402.
46. Chinnaiyan K M, Alexander D, Maddens M and McCullough P A (2007) Curriculum in cardiology: Integrated diagnosis and management of diastolic heart failure. American Heart Journal 153 (2), pp. 189-200.
47. Chow A W C, Lane R E and Cowie M R (2003) New pacing technologies for heart failure. British Medical Journal 326 (7398), pp. 1073-1077.
48. Cintron G, Bigas C, Linares E, Aranda J M and Hernandez E (1983) Nurse practitioner role in chronic congestive heart failure clinic: in hospital time, costs, and patient satisfaction. Heart and Lung 12 (3), pp. 237-240.
49. Clark A and Nadash P (2004) The effectiveness of a nurse-led transitional care model for patients with congestive heart failure. Home Healthcare Nurse 22 (3), pp. 160-162.
50. Clark A L and Coats A J S (2000) Unreliability of cardiothoracic ratio as a marker of left ventricular impairment: Comparison with radionuclide ventriculography and echocardiography. Postgraduate Medical Journal 76 (895), pp. 289-291.
51. Clarke K W, Gray D and Hampton J R (1995) How common is heart failure? Evidence from PACT (prescribing analysis and cost) data in Nottingham. Journal of Public Health Medicine 17 (4), pp. 459-464.
52. Clegg A J, Scott D A, Loveman E, Colquitt J, Hutchinson J, Royle P et al (2005) The clinical and cost effectiveness of left ventricular assist devices for end stage heart failure:a systematic review and economic evaluation. Health Technology Assessment 9 (45), pp. 1-148.
53. Cleland J G, Daubert J C, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. Cardiac Resynchronisation-Heart Failure (CARE-HF) Study Investigators. The New England Journal of Medicine 352 (15), pp. 1539-1549.
54. Coats A J S (2001) What causes the symptoms of heart failure? Heart 86 (5), pp. 574-578.
55. Coats A J S, Adamopoulus S, Radelli A, McCanca A, Meyer T E and Berbadi L (1992) Controlled trial of physical training in heart failure. Circulation 85 (6), pp. 2119-2131.
56. Cody R J, Kubo S H and Pickworth K K (1994) Diuretic treatment for the sodium retention of congestive heart failure. Archives of Internal Medicine 154 (17), pp. 1905-1914.
57. Cody R J and Pickworth K K (1994) Approaches to diuretic therapy and electrolyte imbalance in congestive heart failure. Cardiology Clinics 12 (1), pp. 37-50.
58. Cohn J N and Tognoni G (2001) Randomised trial of the angiotensin receptor blocker valsartan in chronic heart failure. The Valsartan Heart Failure Trial Investigators. The New England Journal of Medicine 345 (23), pp. 1667-1675.
59. Collins S D, Baffour R and Waksmans R (2007) Cell therapy in myocardial infarction. Cardiovascular Revascularisation Medicine: including Molecular Interventions 8 (1), pp. 43-51.
60. Colucci W S, Packer M, Bristow M R, Gilbert E M, Cohn J N, Fowler M B et al. (1996) Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation 94 (11), pp. 2800-2806.
61. Connolly M J, Crowley J J and Vestral R E (1992) Clinical significance of crepitations in elderly patients following acute hospital admission: a prospective study. Age and Aging 21 (1), pp. 43-8.
62. Connolly S J, Hallstrom A P, Cappato R, Schron E B, Kuck K H, Zipes D P et al. (2000a) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator Study.
63. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. European Heart Journal 21 (24), pp. 2071-2078.
64. Connolly S J, Gent M, Roberts R S, Doarian P, Roy D, Sheldon R S, et al. (2000b) Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101 (11), pp. 1297-1302.
65. Constanzo M R, Guglin M, Saltzberg M T, Jessup M L, Bart B A, Teerlink J R, et al (2007) Ultrafiltration versus intravenous diuretics for patients hospitalised for acute decompensated heart failure. Journal of the American College of Cardiology 49 (6), pp. 675-683.
66. Cook D J (1990) Clinical assessment of central venous pressure in the critically ill. The American Journal of Medical Sciences 299 (3), pp. 175-178.
67. Cooper H A, Exner D V and Domanski, M J (2000) Light to moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. Journal of the American College of Cardiology 35 (7), pp. 1753-1759.
68. Coviello J S and Nystrom K V (2003) Obesity and heart failure. The Journal of Cardiovascular Nursing 18 (5), pp. 360-366.
69. Cowie M R and Kirby M (2003) Managing heart failure in primary care: a practical guide. Chipping Norton: Bladon Medical Publishing.
70. Cowie M R, Struthers A D, Wood D A, Coats A J S, Thompson S G, Pole-Wilson P A and Sutton G C (1997) Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. The Lancet 350 (9088), pp. 1349-1352.
71. Cowie M R, Wood D A, Coats A J S, Thompson S G, Poole-Wilson P A, Suresh V et al. (1999) Incidence and aetiology of heart failure: a population-based study. European Heart Journal 20 (6), pp. 421-428.
72. Cowie M R, Wood D A, Coats A J S, Thompson S G, Suresh V, Poole-Wilson P A et al. (2000) Survival of patients with a new diagnosis of heart failure: a population based study. Heart 83 (5), pp. 505-510.
73. Crawford P and Hendry A (1997) Investigation of left ventricular dysfunction in acute dyspnoea. British Medical Journal 314 (7085), pp. 936-940.
74. Curtis J P, Selter J G, Wang Y, Rathore, S S, Jovin I S, Jadbabaie F et al. (2005) The obesity paradox: body mass index and outcomes in patients with heart failure. Archives of Internal Medicine 165 (1), pp. 55-61.
75. Davenport C, Cheng E Y L, Kwok Y T T, Lai A H O, Wakabayashi T, Hyde C et al. (2006) Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis. The British Journal of General Practice 56 (522), pp. 48-56.
76. Davie A P and McMurray J (1997) Investigation of left ventricular dysfunction in acute dyspnoe. A 100% sensitivity would be difficult to achieve. British Medical Journal Letters 315 (7108), p. 604.
77. Davie A P, Francis C M, Love M P, Caruna L, Starkey I R, Shaw T R D et al (1996a) Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. British Medical Journal 312 (7025), pp. 222-225.
78. Davie A P, Love M P and MacMurray J J V (1996b) Value of the electrocardigram in identifying heart failure due to left ventricular systolic dysfunction. British Medical Journal 313 (7052), pp.300-301.
79. Davies M K, Hobbs F D R, Davis R C, Kenkre J E, Roalfe A K, Hare R et al. (2001) Prevalence of left-ventricular systolic dysfunction and heart failure in the echocardiographic heart of England screening study: a population based study. The Lancet 358 (9280), pp. 439-444.
80. Davis R C, Hobbs F D R and Lip G Y H (2000) ABC of heart failure: history and epidemiology. British Medical Journal 320 (7226), pp. 39-42.
81. Davison R and Cannon R (1974) Estimation of central venous pressure by examination of jugular veins. American Heart Journal 87 (3), pp. 279-282.
82. Davos C H, Doehner W, Rauchhaus M, Cicoira M, Francis D P, Coats A J S et al. (2003) Body mass index and survival in patients with chronic heart failure without cachexia; the importance of obesity. Journal of Cardiac Failure 9 (1), pp. 29-35.
83. Dawn B, Zuba-Surma E K, Abdel-Latif A, Tiwari S and Bolli R (2005) Cardiac stem cell therapy for myocardial regeneration: a clinical perspective. Minerva Cardioangiologica Europa 53 (6), pp. 549-564.
84. DeBusk R, Drory Y and Goldstein I et al. (2000) Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. American Journal of Cardiology 86 (2), pp. 175-181.
85. Demopoulus L, Yeh M and Gentilucci M (1997) Non-selective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure. Circulation 95 (7), pp. 1764-1767.
86. Department of Health (2000a) The NHS Plan. London: HMSO.
87. Department of Health (2000b) National Service Framework for Coronary Heart Disease. London: HMSO.
88. Department of Health (2003) Developing Services for Heart Failure. London: HMSO.
89. Dincer H E and O'Neill W (2005) Deleterious effects of sleep disordered breathing on the heart and vascular system. Respiration 73 (1), pp. 124-130.
90. Djousse L, Levy D, Benjamin E J, Blease S J, Russ A, Alrson M G et al. (2004) Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. The American Journal of Cardiology 93 (6), pp. 710-713.
91. Doust J A, Pietrzak E, Dobson A and Glasziou P P (2005) How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. British Medical Journal 330 (7492), p. 625
92. Doval H C, Nul D R, Grancelli H O, Perrone S V, Bortman G R and Curiel R (1994) Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). The Lancet 344 (8921), pp. 493-498.
93. Doyle J J, Neugut A I, Jacobsen J S, Grann V R and Hershman D L (2005) Chemotherapy and cardiotoxicity in older breast cancer patients; a population based study. Journal of Clinical Oncology 23 (34), pp. 8597-8605.
94. Drazner J H, Rame J E and Dries D L (2003) Third heart sound and elevated jugular venous pressure as markers of the subsequent development of heart failure in patients with asymptomatic left ventricular dysfunction. American Journal of Medicine 114 (6), pp. 499-500.
95. Dubrey S W, Cha K, Skinner M, LaValley M and Falk R H (1997) Familial and primary (AL) cardiac amyloidosis: echocardiographically similar disease with distinctly different clinical outcomes. Heart 78 (1), pp. 74-82.
96. Eilen S D, Crawford M H and O'Rourke R A (1983) Accuracy of precordial palpitation for detecting increased left ventricular volume. Annals of Internal Medicine 99 (5), pp. 628-630.
97. Elhendy A, Sozzi F, Van Domburg R T, Bax J J, Schinkel A F L, Roelandt J R T C et al. (2005) Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischaemic cardiomyopathy. American Journal of Cardiology 96 (4), pp. 469-473.
98. Elkayam U, Tasissa G, Binanay C, Stevenson L W, Gheorghiade M, Warnica J W et al. (2007) Use and impact of inotropes and vasodilator therapy in hospitalised patients with severe heart failure. American Heart Journal 153 (1), pp. 98-104.
99. Erbs S, Linke A, Gielen S, Fiehn E, Walther C, Yu J et al. (2003) Exercise training in patients with severe chronic heart failure: impact on left ventricular performance and cardiac size. A retrospective analysis of the Leipzig Heart Failure Training Trial. European Journal of Cardiovascular Prevention and Rehabilitation 10 (5), pp. 336-344.
100. Erbs S, Linke A and Hambrecht R (2006) Effects of exercise training on mortality in patients with coronary heart disease. Coronary Artery Disease 17 (3), pp. 219-225.
101. Erickson V S, Westlake C A, Dracup K A, Woo M A and Hage A (2003) Sleep disturbance symptoms in patients with heart failure. AACN Clinical Issues: Advanced Practice in Acute and Critical Care 14 (4), pp. 477-487.
102. Evangelista L S and Miller P S (2006) Overweight and obesity in the context of heart failure:implications for practise and future research. Journal of Cardiovascular Nursing 21 (1), pp. 27-33.
103. Evangelista L S, Doering L V and Dracup K (2000) Usefulness of a history of tobacco and alcohol use in predicting multiple heart failure admission among veterans. The American Journal of Cardiology 86 (12), pp. 1339-1342.
104. Fabrizio L and Regan T J (1994) Alcoholic cardiomyopathy. cardiovascular Drugs and Therapy 8 (1), pp. 89-94.
105. Faris R, Falther M, Purcell H, Pole-Wilson P and Coats A (2006) Diuretics for heart failure. Cochrane Database of Systematic Reviews (1).
106. Feldman A M, de Lissovoy G, Bristow M R, Saxon L A, De Marco T, Kass D A et al. (2005) Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. Journal of the American College of Cardiology 46 (12), pp. 2311-2321.
107. Fleg J L (2002) Can exercise conditioning be effective in older heart failure patients? Heart Failure Reviews 7 (1), pp. 99-103.
108. Floras J S (2005) Sleep apnoea in heart failure: implications of sympathetic nervous system activation for disease progression and treatment. Current Heart Failure Reports 2 (4), pp. 212-217.
109. Flynn K J, Powell L H, Mendes de Leon C F, Munoz R, Eaton C B, Downs D L et al. (2005) Increasing self management skills in heart failure patients: a pilot study. Congestive Heart Failure 11 (6), pp. 297-302.
110. Fonseca C, Mota T, Morais H, Matias F, Costa C, Oliveira A G et al. (2004) The value of the electrocardiogram and chest X-ray for confirming or refuting a suspected diagnosis of heart failure in the community. European Journal of Heart Failure 6 (6), pp. 807-812.
111. Fox K (2004) Accreditation in community echocardiography. British Journal of Cardiology 11 (5), p. 402.
112. Frazier O H (2003) Ventricular assist devices and total artificial hearts: a historical perspective. Cardiology Clinics 21 (1), pp. 1-13.
113. French B A (1998) Gene therapy and cardiovascular disease. Current Opinions in Cardiology 13 (3), pp. 205-213.
114. Fried T, van Doorn C, O'Leary J, Tinetti M and Drickamer M (1999) Older persons preferences for site of terminal care. Annals of Internal Medicine 131 (2), pp. 109-112.
115. Friedmann E, Thomas S A, Liu F, Morton P G, Chapa D and Gottlieb S S (2006) Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. American Heart Journal 152 (5), p. 940.
116. Fuat A, Hungin A P S and Murphy J J (2003) Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. British Medical Journal 326 (7382), p. 196.
117. Galatius S, Gustafsson F, Atar D and Hildebrandt P R (2004) Tolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure-a randomized comparison. Cardiology 102 (3), pp. 160-165.
118. Gasparini M, Regoli F, Galimberti P, Ceriotti C, Bonadies M, Mangiavacchi M et al. (2007) Three years of cardiac resynchronisation therapy: could superior benefits be obtained in patients with heart failure and narrow QRS? Pacing and Clinical Electrophysiology S1 S34-39.
119. Gerecht N S and Itskovitz E J (2004) Human embryonic stem cells: a potential source for cellular therapy. American Journal of Transplantation 4 (S6), pp. 51-57.
120. Gertz M A, Lacy M Q and Dispenzieri A (2005) Amyloidosis: recognition, confirmation, prognosis and therapy. Mayo Clinic Proceedings 74 (5), pp. 490-494.
121. GESICA Investigators (2005) Randomised trial of telephone intervention in chronic heart failure: DIAL trial. British Medical Journal 331 (7514), p. 425.
122. Ghani J K, Kadakia S, Cooper R et al. (1988) Precipitating factors leading to decompensation in heart failure: traits among urban blacks. Archives of Internal Medicine 148 (9), pp. 2013-2016.
123. Gheorghiade M, Abraham W T, Albert N M, Gattis-Stough W, Greenberg B H, O'Conner C M, et al. (2007) Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalised for heart failure: an analysis from the OPTIMIZE-HF registry. European Heart Journal, Advance Access published online on 19 February 2007.
124. Giannuzzi, P (2003) Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial. Circulation 108 (5) pp. 554-559.
125. Gibbs L M E, Hatri A K and Gibbs J S R (2006) Survey of specialist palliative care and heart failure: September 2004. Palliative Medicine 20 (6), pp. 603-609.
126. Gillespie N D, McNeil G, Pringle T, Ogston S, Struthers A D and Pringle S D (1997) Cross sectional study of the contribution of clinical assessment and simple cardiac investigations to the diagnosis of left ventricular systolic function in patients with acute dyspnoea. British Medical Journal 314 (7085), pp. 936-940.
127. Gold L D and Krumholz H M (2006) Gender differences in treatment of heart failure and acute myocardial infarction: a question of quality or epidemiology? Cardiology in Review 14 (4), pp. 180-186.
128. Goldstein S (2004) The changing epidemiology of sudden death in heart failure. Current Heart Failure Reports 1 (3), pp. 93-97.
129. Good C B, McDermott L and McCloskey B (1995) Diet and serum potassium in patients on ACE inhibitors. Journal of the American Medical Association 274 (7), p. 538.
130. Gustafsson I, Torp-Pederson C, Kober L, Gustafsson F and Hilberant P (1999) Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. Trace Study Group. Journal of the American College of Cardiology 34 (1), pp. 83-89.
131. Gwadry-Sridhar F H, Arnold J M, Zhang Y, Brown J E, Marchiori G and Guyatt G (2005) Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalised with heart failure. American Heart Journal 150 (5), pp. 982-989.
132. Gwinnutt C L, Columb M and Harris R (2000) Outcome after cardiac arrest in adults in UK hospitals: effect of the 1997 guidelines. Resuscitation 47 (2), pp. 125-135.
133. Hall J A, French T K, Rasmusson K D, Vesty J C, Roberts C A, Rimmasch H L et al. (2005) The paradox of obesity in patients with heart failure. Journal of the American Academy of Nurse Practitioners 17 (12), pp. 542-546.
134. Hambleton M, Hahn H, Pleger S T, Kuhn M C, Klevitsky R, Carr A N et al. (2006) Pharmaceutical and gene based inhibition of protein kinase Cαβ enhances cardiac contractility and attenuates heart failure. Circulation 114 (6), pp. 574-582.
135. Hambrecht R, Fiehn E and Neibaier J (1997) Effects of endurance training on mitochondrial ultrastructure and fibre type distribution in skeletal muscles of patients with stable chronic heart failure. Journal of the American College of Cardiology 29 (5), pp. 527-537.
136. Hamner J B and Ellison K J (2005) Predictors of hospital readmission after discharge in patients with congestive heart failure. Heart and Lung 34 (4), pp. 231-239.
137. Hanumanthu S, Butler J, Chomsky D et al (1997) Effect of heart failure program on hospitalisation frequency and exercise tolerance. Circulation 96 (9), pp. 2842-2848.
138. Harlan W R (1977) Chronic congestive heart failure in coronary artery disease: clinical criteria. Annals of Internal Medicine 86 (2), pp. 133-138.
139. Harrison M B, Browne G B, Roberts J, Tugwell P, Gafni A and Graham I D (2002) Quality of life of individuals with heart failure: a randomized trial of the effectiveness of two models of hospital-to-home transition. Medical Care 40 (4), pp. 271-282.
140. Hill E E, Herijgers P, Claus P, Vanderschueren S, Herregods M C and Peetermans W E (2007) Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. European Heart Journal 28 (2), pp. 196-203.
141. Hobbs F D (2000) Management of heart failure: evidence versus practice. Does current prescribing provide optimal treatment for heart failure patients? The British Journal of General Practice 50 (458), pp. 735-42.
142. Holland R, Battersby J, Harvey I, Lenaghen E, Smith J and Hay L (2005) Systematic review of multidisciplinary interventions in heart failure. Heart 91 (7), pp. 899-906.
143. Hooley P J, Butler G and Howlett J G (2005) The relationship of quality of life, depression, and caregiver burden in outpatients with congestive heart failure. Congestive Heart Failure 11 (6), pp. 303-310.
144. Houghton A R, Sparrow N J, Toms E and Cowley A J (1997) Should general practitioners use the electrocardiogram to select patients with suspected heart failure for echocardiography? International Journal of Cardiology 62 (1), pp. 31-36.
145. Hunt S A, Baker D W, Chin M H, Cinquegrani M P, Feldman A M, Francis G S et al. (2001) ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult. Bethseda: American College of Cardiology.
146. Ismail A A, Wing S, Ferguson J, Hutchinson T A, Magder, S and Flegel K M (1987) Interobserver agreement by auscultation in the presence of a third heart sound in patients with congestive heart failure. Chest 91 (6), pp. 870-3.
147. Jaarsma T and Dracup K (2001) Determinisation of health care utilisation by patients with chronic heart failure. In Stewart S and Blue L, Chronic Heart Failure: a Practical Guide to Specialist Nurse Intervention. London: BMJ Books.
148. Jaarsama T, Stromberg A, De Geest S, Fridlund B, Heikkila J, Martensson J et al. (2006) Heart failure management programmes in Europe. European Journal of Cardiovascular Nursing 5 (3), pp. 197-205.
149. Jackson G, Gibbs C R, Davies M K and Lip, G Y (2000) ABC of heart failure:pathophysiology. British Medical Journal 320 (7228), pp. 167-170.
150. Jacob A J, McLaren K M and Boon N A (1991) Effects of abstinence on alcoholic heart muscle disease. American Journal of Cardiology 68 (8), pp. 805-807.
151. Januzzi J L, Van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M et al. (2005) NT-proBNP testing for diagnosis and short term prognosis in acute destabilised heart failure: an international analysis of 1256 patients. European Heart Journal 27 (3), pp. 330-337.
152. Jessup M and Brozena S C (2003) Support devices for end stage heart failure. Cardiology Clinics 21 (1), pp. 135-139.
153. Joekes K, Elderen T van and Schreurs K (2007) Self-efficacy and overprotection are related to quality of life, psychological well-being and self-management in cardiac patients. Journal of Health Psychology 12 (1), pp. 4-16.
154. Jolly L (2002) The role of the specialist nurse. Heart 88 (SII), pp. ii33-ii35.
155. Joshi N (1999) The third heart sound. Southern Medical Journal 92 (8), pp. 756-61.
156. Jovicic A, Holroyd L J M and Straus S E (2006) Effects of self-management intervention on health outcomes of patients with heart failure: a systematic review of randomized controlled trials. BMC Cardiovascular Disorders 6 (1), pp. 43-51.
157. Juenger J, Schelberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W et al. (2002) Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 87 (3), pp. 235-41.
158. Juurlink D N, Mamdani M M, Lee D S, Kopp A, Austin P C, Laupacis A et al. (2004) Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. The New England Journal of Medicine 351 (6), pp. 543-551.
159. Kamath S A, Meo N J D P, Canham R M, Uddin F, Toto K H, Nelson L L et al. (2006) Low voltage on the electrocardiogram is a marker of disease severity and a risk factor for adverse outcomes in patients with heart failure due to systolic dysfunction. American Heart Journal 152 (2), pp. 355-361.
160. Kannel W B and Belanger A J (1991) Epidemiology of heart failure. American Heart Journal 121 (3), pp. 951-957.
161. Kannel W B (2000) Incidence and epidemiology of heart failure. Heart Failure Reviews 5 (2), pp. 167-173.
162. Kareti K R, Chiong J R, Hsu S S and Miller A B (2005) Congestive heart failure and atrial fibrillation: rhythm versus rate control. Journal of Cardiac Failure 11 (3), pp. 164-172.
163. Kellerman J J, Shemesh J and Ben-Ari E (1988) Contraindications to physical training in patients with impaired ventricular function. European Heart Journal 9 Supplement F, pp. 71-76.
164. Kenchaiah S, Evans J C, Levy D, Wilson P W, Benjamin E J, Larson M G et al. (2002) Obesity and the risk of heart failure. The New England Journal of Medicine 347 (5), pp. 303-313.
165. Kernan W N, Castellsague J, Perlman G D and Ostfeld A (1994) Incidence of hospitalization for digitalis toxicity among elderly Americans. The American Journal of Medicine 96 (5), pp. 426-431.
166. Kervio G, Ville N S, Leclercq C, Daubert J C and Carre F (2004) Intensity and daily reliability of the six-minute walk test in moderate chronic heart failure patients. Archives of Physical Medicine and Rehabilitation 85 (9), pp.1513-1518.
167. Khan N A, Ma I, Thompson C R, Humphries K, Salem D N, Sarnak M J and Levin A (2005) Kidney function and mortality among patients with left ventricular systolic dysfunction. Journal of the American Society of Nephrology 17 (1), pp. 244-253.
168. Kjekshus J, Swedberg K and Sanpinn S (1992) Effects on enalapril on long term mortality in severe congestive heart failure. CONSENSUS Trial Group. American Journal of Cardiology 69 (1), pp. 103-107.
169. Klatsky A L, Chartier D, Udaltsova N, Gronningen S, Brar S, Freidman G D and Lundstrom R J (2005) Alcohol drinking and risk of hospitalisation for heart failure with and without associated coronary artery disease. The American Journal of Cardiology 96 (3), pp.346-351.
170. Konstam M A, Neaton J D, Poole-Wilson P A, Pitt B, Segal R, Sharma D et al. (2005) Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II). American Heart Journal 150 (1), pp. 123-131.
171. Kornowski R, Zeeli D, Averbach M (1995) Intensive home surveillance prevents hospitalisation and improves morbidity rates among elderly patients with severe congestive heart failure. American Heart Journal 129 (4), pp. 762-766.
172. Krantrowitz A, Tjonneland S, Freed P S, Philips S J, Butner A N and Sherman J N Jnr. (1968) Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. Journal of the American Medical Association 203 (2), pp. 113-118.
173. Kuck K H, Cappato R, Siebels J and Ruppel R (2000) Randomized comparison of antiarrythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102 (7), pp. 748-754.
174. Lackey J (2004) Cognitive impairment and congestive heart failure. Nursing Standard 18 (44), pp. 33-36.
175. Lakka H M, Lakka T A, Tuomilehto J and Salomnen J T (2002) Abdominal obesity is associated with increased risk of acute coronary events in men. European Heart Journal 23 (9), pp. 706-713.
176. Lampert M B and Lang R M (1995) Peripartum cardiomyopathy. American Heart Journal 130 (4), pp. 860-870.
177. Latour-Perez J, Covesorts F J, Abad-Terrado C, Abraira V and Zamora J (2005) Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review. European Journal of Heart Failure 8 (4), pp. 390-399.
178. Lauer M S, Anderson K M, Kannel W B and Levy D (1991) The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study. Journal of the American Medical Association 266 (2), pp. 231-236.
179. Lee W K and Regan T J (2002) Alcoholic cardiomyopathy: is it dose dependent? Congestive Heart Failure 8 (6), pp. 303-6.
180. Lemola K, Brunckhorst C, Helfenstein U, Oeschslin E, Jenni R and Duru F (2005) Predictors of adverse outcome in patients with arrythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary centre. Heart 91 (9), pp. 1167-1172.
181. Leslie S J, Emmanuel Y, Francis C M and Flapan A D (2004) The treatment of peripartum cardiomyopathy. British Journal of Cardiology 11 (5), pp. 393-396.
182. Levick J R (1995) An Introduction to Cardiovascular Physiology, 2nd Edition, Oxford:Butterworth-Heinemann.
183. Lightwood J M and Glantz S A (1997) Short term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation 96 (4), pp. 1089-1096.
184. Linde C, Braunschweig F, Gadler F, Bailleul C and Daubert J C (2003) Long-term improvements in quality of life by biventricular pacing in patients with chronic heart failure: results from the Multisite Stimulation in Cardiomyopathy study (MUSTIC). The American Journal of Cardiology 91 (9), pp. 1090-1095.
185. Lipiecki J, Durel N and Ponsonnaille J (2006) Which patients with ischaemic heart disease could benefit from cell replacement therapy? European Heart Journal 8 Supplement, H3-7.
186. Lloyd-Williams F, Mair F S and Leitner, M (2002) Exercise training and heart failure:a systematic review of current evidence. British Journal of General Practice 52 (474), pp. 47-55.
187. Lloyd-Williams F, Beaton S, Goldstein P, Mair F, May C and Capewell S (2005) Patients' and nurses' views of nurse-led heart failure clinics in general practice: a qualitative study. Chronic Illness 1 (1), pp. 39-47.
188. Lyratzopoulos G, Cook G A, McElduff P, Havely D, Edwards R and Heller R F (2004) Assessing the impact of heart failure specialist services on patient populations. BMC Health Services Research 4 (1), p. 10.
189. Madsen B K, Videbaek R, Stokholm H M, Mortensen L S and Hansen J F (1996) Prognostic value of echocardiography in 190 patients with chronic congestive heart failure:a comparison with New York Heart Association functional classes and radionuclide ventriculography. Cardiology 87 (3), p. 250-256.
190. Mahmudi M, McDonagh S, Poole-Wilson P A and Dubrey S W (2003) Obstacles to the initiation of beta-blockers for heart failure in a specialised clinic within a district general hospital. Heart 89 (4), pp. 422-444.
191. Mair F S, Crowley T S and Bundred P E (1996) Prevalence, aetiology and management of heart failure in general practice. The British Journal of General Practice 46 (403), pp. 77-79.
192. Malki Q, Sharma N D, Afzal A, Ananthsubramaniam K, Abbas A, Jacobson G and Jafri S (2002) Clinical presentation, hospital length of stay, and readmission rate in patients with heart failure with preserved and decreased left ventricular systolic function. Clinical Cardiology 25 (4), pp. 149-152.
193. Mancini D M, Walter G, Reichek N, Lenkinski R, McCully R, Mullen J L and Wilson J R (1992) Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85 (4), pp. 1364-1373.
194. Marcus F, Towbin J A, Zareba W, Moss A, Calkins H, Brown M and Gear K (2003) Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C):a multidisciplinary study: design and protocol. Circulation 107 (23), pp. 2975-2978.
195. Mariotti R, Castrogiovanni F, Becherini F, Cortese B, Rondini L and Mariani M (2004) Obesity, weight loss and heart failure. European Heart Journal Supplement 6 (6), F87-90.
196. Maron B J, Towbin J A, Thiene G, Antzelevitch C, Corrado D, Arnett D et al. (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes research and Functional Genomics and Transitional Biology Interdisciplinary Working Group; and Council on Epidemiology and Prevention. Circulation 113 (14), pp. 1807-1816.
197. Martensson J, Stromberg A, Dahlstrom U, Karlsson J E and Fridlund B (2005) Patients with heart failure in primary health care: effects of a nurse-led intervention on health-related quality of life and depression. European Journal of Heart Failure 7 (3), pp. 393-403.
198. Massie B M (2002) Obesity and heart failure-risk factor or mechanism? The New England Journal of Medicine 347 (5), pp. 358-360.
199. Masson S, Latini R, Anand I S, Vago T, Angelici L, Barlera S et al. (2006) Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the valsartan heart failure (Val-HeFT) data. Clinical Chemistry 52 (8), pp. 1528-1538.
200. Matsui Y, Fukada Y, Naito Y, Sasaki S and Yasuda, K (2005) A surgical approach to severe congestive heart failure-overlapping ventriculoplasty. Journal of Cardiovascular Surgery 20 (S6), S29-S34.
201. Mazza A, Tikhonoff V, Casiglia E and Pessina A C (2005) Predictors of congestive heart failure mortality in elderly people from the general population: The Cardiovascular Study in the Elderly (CASTEL). International Heart Journal 46 (3), pp. 419-431.
202. McAlister F A, Stewart S, Ferrua S and McMurray J J V (2004) Multidisciplinary strategies for the management of heart failure patients at high risk for admission. Journal of the American College of Cardiology 44 (4), pp. 810-819.
203. McCormick S A (1999) Advanced practice nursing for congestive heart failure. Critical Care Nursing Quarterly 21 (4), pp. 1-8.
204. McDonagh T A (2002) Screening for left ventricular dysfunction: a step too far? Heart 88 Supplement 2, pp. ii12-4.
205. McDonagh T A, Morrison C E, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray J J and Dargie H J (1997) Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 350 (9081), pp. 829-833.
206. McElvie R S, Teo K K, McCartney N, Humen D, Montague T and Yusuf S (1995) Effects of exercise training in patients with congestive heart failure: a critical review. Journal of the American College of Cardiology 25 (3), pp. 789-796.
207. McElvie R S, Yusuf S, Pericak D, Avezum A, Burns R J, Probstfield J et al. (1999) Comparison of candesartan, enalapril, and their combination in congestive heart failure:randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation 100 (10), pp. 1056-1064.
208. Mehta R and Feldman D (2005) Acute decompensated heart failure: best evidence and current practices. Minerva Cardioangiologica Europa 53 (6), pp. 537-547.
209. Menash G A, Mokdad A H, Ford E S, Greenlund K J and Croft J B (2005) State of disparities in cardiovascular health in the United States. Circulation 111 (10), pp. 1233-1241.
210. Meredith P A and Östergren J (2006) From hypertension to heart failure-Are there better primary prevention strategies? Journal of the Renin-Angiotensin-Aldosterone System 7 (2), pp. 64-73.
211. MERIT-HF Study Group (1999) Effect of metoprolol CR/XL in chronic heart failure:metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). The Lancet 353 (9169), pp. 2001-2007.
212. Merritt S L (2004) Sleep disordered breathing and the association with cardiovascular risk. Progress in Cardiovascular Nursing 19 (1), pp. 19-27.
213. Meyer J A (1990) Werner Forssmann and catheterization of the heart, 1929. The Annals of Thoracic Surgery 49 (3), pp. 497-499.
214. Meyer F J, Borst M M, Zugck C, Kirscke A, Schellberg D, Kubler W and Haass M (2001) Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation 103 (17), pp. 2153-2158.
215. Meyer T E, Casadei B, Coats A J S, Davey P P, Adamopoulos S, Radaelli A et al. (1991) Angiotensin converting enzyme inhibition and physical training in heart failure. Journal of Internal Medicine 230 (5), pp. 407-413.
216. Michalson A, Konig G and Thimme W (1998) Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 80 (5), pp. 437-441.
217. Middlekauff H R, Stevenson W G and Saxon L A (1993) Prognosis after syncope: impact of left ventricular function. American Heart Journal 125 (1), pp. 121-127.
218. Mølgaard H, Kristensen B O and Baandrup U (1990) Importance of abstention from alcohol in alcoholic heart disease. International Journal of Cardiology 26 (3), pp. 373-375.
219. Morrison, D (2006) PCI versus CABG versus medical therapy in 2006. Minerva Cardioangiologica Europa 54 (5), pp. 643-672.
220. Moser D K, Lennie T A and Doering L V (2004) Non-pharmacologic management of heart failure. In Stewart S, Moser D K and Thompson D R, Caring for the Heart Failure Patient: A Textbook for the Health Care Professional. London: Martin Dunitz.
221. Moser D K, Doering L V and Chung M L (2005) Vulnerabilities of patients recovering from an exacerbation of chronic heart failure. American Heart Journal 150 (5), p. 984.
222. Moss A J, Zareba W, Jackson Hall W, Klein H, Wilber D J, Cannon D S et al. (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. The New England Journal of Medicine 346 (12), pp. 877-883.
223. Mosterd A, Hoes A W, deBruyne M C, Deckers J W, Linker J W, Hofman A and Grobbee D E (1999) Prevalence of heart failure and left ventricular dysfunction in the general population: the Rotterdam Study. European Heart Journal 20 (6), pp. 447-455.
224. Mukamal K J, Tolstrup J S, Friberg J, Jenson G and GrønbaekM (2005) Alcohol consumption and risk of atrial fibrillation in men and women: the Copenhagen City Heart Study. Circulation 112 (12), pp. 1736-1742.
225. Murphy R T and Starling R T (2005) Genetics and cardiomyopathy: Where are we now? Cleveland Clinic Journal of Medicine 72 (6), pp. 465-483.
226. Murray S A, Boyd K, Kendall M, Worth A, Benson T F and Clausen H (2002) Dying of lung cancer or cardiac failure: prospective qualitative interview study of patients and their carers in the community. British Medical Journal 325 (7370), pp. 929-932.
227. Nazarian S, Maisel W H, Miles J S, Tsang S, Stevenson L W and Stevenson W G (2005) Impact of implantable cardioverter defibrillators on survival and recurrent hospitalisation in advanced heart failure. American Heart Journal 150 (5), pp. 955-960.
228. Ng E, Stafford P J and Ng G A (2004) Arrhythmia detection by patient and auto-activation in implantable loop recorders. Journal of Interventional Cardiac Electrophysiology 10 (2), pp. 147-152.
229. NICE (2003) Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care, NICE: London.
230. Nicklas B J, Cesari M, Penninx B M J, Kritchevsky S B, Ding J, Newman A et al. (2006) Abdominal obesity is an independent risk factor for chronic heart failure in older people. Journal of the American Geriatrics Society 54 (3), pp. 413-420.
231. Nicolozakes A W, Binkley P F and Leier C V (1988) Haemodynamic effects of smoking in congestive cardiac failure. American Journal of Medical Science 296 (6), pp. 377-380.
232. North T C, McCullough P and Tran Z V (1990) Effect of exercise on depression. Exercise Sport Science Review 18 (1), pp. 379-415.
233. O'Neill T W, Barry M, Smith M and Graham I M (1989) Diagnostic value of the apex beat. Lancet 2 (8661), pp. 410-11.
234. Oshima K, Morishita Y, Hinohara H, Kadoi Y, Hayashi Y, Tajima Y and Kunimoto F (2005) Prolonged use for at least ten days of intraaortic balloon pumping (IABP) for heart failure. International Heart Journal 46 (6), pp. 1041-1047.
235. Pachori A S, Melo L G and Dzau V J (2006) Gene therapy: role in myocardial protection. Handbook of Experimental Pharmacology 176 (2), pp. 335-350.
236. Packer M, Gheorghiade M, Young J B, Costantini P J, Adams K F, Cody R J et al. (1993) Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study. The New England Journal of Medicine 329 (1), pp. 1-7.
237. Packer M, Bristow M R, Cohn J N, Colucci W S, Fowler M B, Gilbert E M et al. (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. The New England Journal of Medicine 334 (21), pp. 1349-1355.
238. Packer M, Poole-Wilson P A, Armstrong P W, Cleland J G, Horowitz J D, Massie B M et al. (1999) Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 100 (23), pp. 2312-2318.
239. Packer M, Abraham W T, Mehra M R, Yancy C W, Lawless C E, Mitchell J E et al. (2006) Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. Journal of the American College of Cardiology 47 (11), pp. 2245-2252.
240. Palmer N D, Appleton B and Rodrigues E A (2003) Specialist nurse-led intervention in outpatients with congestive heart failure: impact on clinical and economic outcomes. Disease Management Health Outcomes 11 (11), pp. 693-698.
241. Panina G, Khot U N, Nunziata E, Cody R J and Binkley P F (1995) Assessment of autonomic tone over a 24-hour period in patients with congestive heart failure: relation between mean heart rate and measures of heart rate variability. American Heart Journal 129 (4), pp. 748-753.
242. Parikh S and de Lemos J A (2005) Current therapeutic strategies in cardiac amyloidosis. Current Treatment Options in Cardiovascular Medicine 7 (6), pp. 443-448.
243. Park E W, Schultz J K, Tudiver F, Campbell T and Becker L (2004) Enhancing partner support to improve smoking cessation. Cochrane Database of Systematic Reviews, 3.
244. Partridge G (2004) Echocardiography in the community: mind the gap. British Journal of Cardiology 11 (5), pp. 403-404.
245. Patel A N, Geffner L, Vina R F, Saslavsky J, Urschel H C Jnr, Kormos R and Benneti F (2005) Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomised study. Journal of Thoracic Cardiovascular Surgery 130 (6), pp. 1631-1638.
246. Patel R, Bushness D L and Sobotka P A (1993) Implications of an audible third heart sound in evaluating cardiac function. The Western Journal of Medicine 158 (6), pp. 606-609.
247. Peacock W F, Albert N M, White R D and Emerman C L (2000) Bioimpedance monitoring:better than chest x-ray for predicting abnormal pulmonary fluid? Congestive Heart Failure 6 (2), pp. 86-89.
248. Perin E, Dohmann H F R, Borojevic R, Silva S A, Sousa A L S, Mesquita C T et al. (2003) Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischaemic heart failure. Circulation 107 (18), pp. 2294-2302.
249. Persson H, lonn E, Edner M, Barach L, Lang C C, Morton J J et al. (2007) Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM echocardiographic sub study-CHARMES. Journal of the American College of Cardiology 49 (6), pp. 687-694.
250. Pfeffer M A, Braunwald E, Moye L A, Basta L, Brown E J Jnr, Cuddy T E et al. (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. The New England Journal of Medicine 327 (10), pp. 669-677.
251. Phillips C O, Singa R M, Rubin H R and Jaarsma T (2005) Complexity of program and clinical outcomes of heart failure disease management incorporating specialist nurse-led heart failure clinics. A meta-regression analysis. European Journal of Heart Failure 7 (3), pp. 333-341.
252. Piano M R (2002) Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest 121 (5), pp. 1638-1650.
253. Piano M R and Schwertz D W (1994) Alcoholic heart disease: a review. Heart and Lung 23 (1), pp. 3-17.
254. Piepoli M F, Flather M and Coats A J S (1998a) Overview of studies of exercise training in chronic heart failure: the need for a prospective multicentre European trial. European Heart Journal 19 (6), pp. 830-841.
255. Piepoli M, Villani G Q, Ponikowski P, Wright A, Falther M D and Coats A J (1998b) Overview and meta-analysis of randomised trials of amiodarone in chronic heart failure. International Journal of Cardiology 66 (1), pp. 1-10.
256. Piepoli M F, Davos C, Francis D P and Coats A J S (2004) Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). British Medical Journal 328 (7433), pp. 189-196.
257. Pitt B, Segal R, Martinez F A, Meurers G, Cowley A J, Thomas I et al. (1997) Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly study, ELITE). The Lancet 349 (9054), pp. 747-752.
258. Pitt B, White H, Nicolau J, Martinez F, Gheorghiade M, Aschermann M et al. (2005) Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure. Journal of the American College of Cardiology 46 (3), pp. 425-31.
259. Pocar M, Moneta A, Adalberto G and Donatelli F (2007) Coronary artery bypass for heart failure in ischemic cardiomyopathy: 17-year follow-up. The Annals of Thoracic Surgery 83 (2), pp. 468-474.
260. Poole-Wilson P A, Swedberg K, Cleland J G F, DiLenarda A, Hanrath P, Komajada M et al. (2003) Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol European trial (COMET): randomised controlled trial. The Lancet 362 (9377), pp. 7-13.
261. Powell B D, Redfield M M, Bybee K A, Freeman W K and Rihal C S (2006) Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease. The American Journal of Cardiology 98 (1), pp. 116-120.
262. Pu C T, Johnson M T, Forman D E, Hausdorff J M, Roubenoff R and Foldarvi M (2001) Randomised trial of progressive resistance to exercise training to counteract the myopathy of chronic heart failure. Journal of Applied Physiology 90 (6), pp. 2341-2350.
263. Ramasamy R, Hildebrandt T, O'Hea E, Patel M, Clemow L, Freudenberger R and Skotzko C (2006) Psychological and social factors that correlate with dyspnoea in heart failure. Psychosomatics 47 (5), pp. 430-434.
264. Rector T S, Anand I S and Cohn J N (2006) Relationships between clinical assessments and patients' perceptions of the effects of heart failure on their quality of life. Journal of Cardiac Failure 12 (2), pp. 87-92.
265. Remes J, Miettenin H, Reunanan A and Pyorala K (1991) Validity of clinical diagnosis of heart failure in primary health care. European Heart Journal 12 (3), pp. 315-321.
266. Rexrode, K M, Carey, V J, Hennekems, C H et al. (1998) Abdominal adiposity and coronary heart disease in women. Journal of the American Heart Association 280 (21), pp. 1843-1848.
267. Rich M W, McSherry F, Williford W O and Yusuf S (2001) Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study. Journal of the American College of Cardiology 38 (3), pp. 806-813.
268. Rosanio S, Schwartz E R, Ahmad M, Jammula P, Vitarelli A, Uretsky B F et al. (2005) Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure. The American Journal of Cardiology 96 (5), pp. 710-717.
269. Rose E A, Gelijns A C, Moskowitz A J, Heitjan D F, Stevenson LWDembtskyWet al. (2001) Long term mechanical left ventricular assistance for end stage heart failure. Randomised evaluation of mechanical assistance for the treatment of congestive heart failure study. The New England Journal of Medicine 345 (20), pp. 1435-1443.
270. Rumsfeld J S, Jones P G, Whooley M A, Sullivan M D, Pitt B, Weintraub W S et al. (2005) Depression predicts mortality and hospitalisation in patients with myocardial infarction complicated by heart failure. American Heart Journal 150 (5), pp. 961-967.
271. Salisbury A C, House J A, Conrad M W, Krumholtz H M and Spertus J A (2005) Low to moderate alcohol intake and health status in heart failure patients. Journal of Cardiac Failure 11 (5), pp. 328-328.
272. Saxon L A, Bristow M R, Boehmer J, Krueger S, Kass D A De Marco T et al. (2006) Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 114 (25), pp. 2766-2772.
273. Scalvini S, Zanelli E, Volterrani M, Martinelli G, Baratti D, Buscaya O, Baiardi P, Glisenti F and Giodano A (2004) A pilot study of nurse led, home based telecardiology for patients with chronic heart failure. Journal of Telemedicine and Telecare 10 (2), pp. 113-117.
274. Schellenbaum G D, Rea T D, Heckbert S R, Smith N L, Lumley T, Roger V L et al. (2004) Survival associated with two sets of diagnostic criteria for congestive heart failure. American Journal of Epidemiology 160 (7), pp. 628-635.
275. Schmitt B P, Kusher M S and Weiner S L (1986) The diagnostic usefulness of the history of the patient with dyspnoea. Journal of General Internal Medicine 1 (6), pp. 386-393.
276. Schocken D D, Arrieta M I, Leaverton P E and Ross E A (1992) Prevalence and mortality rate of congestive heart failure in the United States. Journal of the American College of Cardiology 20 (2), pp. 301-306.
277. Sekiguchi M, Yazaki Y, Isobe M and Hiroe M (1996) Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovascular Drugs and Therapy 10 (5), pp. 495-510.
278. Senni M, Tribouilloy C M, Rodeheffer R J, Jacobsen S J, Evans J M, Bailey K R et al. (1999) Congestive heart failure in the community: trends in incidence and survival in a 10 year period. Archives of Internal Medicine 159 (1), pp. 29-34.
279. Sesti C and Kloner R A (2004) Gene therapy in congestive heart failure. Circulation 110 (3), pp. 242-243.
280. Seth R, Magner P, Matzinger F and van Walraven C (2002) How far is the sternal angle from the mid right atrium? Journal of General Internal Medicine 17 (11), pp. 852-856.
281. Shah M R, Flavell C M, Weintraub J R, Young M A, Hasselblad V, Fang J C et al. (2005) Intensity and focus of heart failure disease management after hospital discharge. American Heart Journal 149 (4), pp. 715-721.
282. Sharpe N and Doughty R (1998) Epidemiology of heart failure and ventricular dysfunction. The Lancet 353 S1, S3-7.
283. Shepler S A and Patel A N (2007) Cardiac cell therapy: a treatment option for cardiomyopathy. Critical Care Nursing Quarterly 30 (1), pp. 74-80.
284. Sherwood A, Blumenthal J A, Trivedi R, Johnson K S, O'Connor C M, Adams K F Jr et al. (2007) Relationship of depression to death or hospitalization in patients with heart failure. Archives of Internal Medicine 167 (4), pp. 367-373.
285. Shin D D, Brandimarte F, DeLuca L, Sabbah H N, Fonarow G C, Filippatos G et al. (2007) Review of current and investigational pharmacologic agents for acute heart failure syndromes. American Journal of Cardiology 99 (2), pp. S4-23.
286. SIGN (2007) Management of Chronic Heart Failure: a National Clinical Guideline, Edinburgh:Scottish Intercollegiate Guidelines Network.
287. Sinoway L I (1988) Effects of conditioning and deconditioning stimuli on metabolically determined blood flow in humans and implications for congestive heart failure. American Journal of Cardiology 62 45E-48E.
288. Sneed N V and Paul S C (2003) Readiness for behavioural changes in patients with heart failure. 1 (5), pp. 444-453.
289. Solomon S D, Anavekar N, Skali H, McMurray J J, Swedberg K, Yusuf S et al. (2005) Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112 (24), pp. 3738-3744.
290. Sosin M D, Bhatia G S, Davis R C and Lip G Y H (2004) Heart failure-the importance of ethnicity. European Journal of Heart Failure 6 (7), pp. 831-843.
291. Spies C D, Sander M, Stangl K, Fernandez S J, Preedy V R, Rubin E et al. (2001) Effects of alcohol on the heart. Current Opinion in Critical Care 7 (5), pp. 337-343.
292. Spyrou N and Foale R (1994) Restrictive cardiomyopathies. Current Opinion in Cardiology 9 (3), pp. 344-348.
293. Squires R W (1985) Moderate altitude exposure and the cardiac patient. Journal of Cardiopulmonary Rehabilitation 5 (9), pp. 421-426.
294. Stevenson W G and Tedrow U (2006) Management of atrial fibrillation in patients with heart failure. Heart Rhythm 4 (3), pp. S28-S30.
295. Stewart A (1989) Functional status and well being of patients with chronic conditions. Journal of the American Medical Association 262 (7), pp. 907-913.
296. Stewart S and Blue L (2001) Improving Outcomes in Chronic Heart Failure: a practical guide to specialist nurse intervention, London: BMJ Books.
297. Stewart S and Horowitz J D (2003) Specialist nurse management programmes: economic benefits in the management of heart failure. Pharmacoeconomics 21 (4), pp. 225-240.
298. Stewart S, Pearson S and Horowitz J D (1998) Effects of a home based intervention among patients with congestive heart failure discharged from acute hospital care. Archives of Internal Medicine 158 (10), pp. 1067-1072.
299. Stewart S, Vandenbroeak A J, Pearson S and Horowitz J D (1999) Prolonged beneficial effects of a home based intervention on unplanned readmissions and mortality among patients with congestive heart failure. Archives of Internal Medicine 159 (3), pp. 257-261.
300. Stewart S, MacIntyre K, Hole D J, Capewell S and McMurray J J (2001) More 'malignant' than cancer? Five-year survival following a first admission for heart failur. European Journal of Heart Failure 3 (3), pp. 315-322,
301. Stewart S, Blue L, Walker A, Morrison C and McMurray J J V (2002) An economic analysis of specialist heart failure nurse management in the UK. Can we afford not to implement it? European Heart Journal 23 (17), pp. 1369-1378.
302. Stewart S, MacIntyre K, Capewell S and McMurray J J V (2003) Heart failure and the aging population: an increasing burden in the 21st century? Heart 89 (1), pp. 49-53.
303. Stramba-Badiale M, Fox K M, Priori S G, Collins P, Daly C, Graham L et al. (2006) Cardiovascular disease in women: a statement from the policy conference of the European Society of Cardiology. European Heart Journal 27 (8), pp. 994-1005.
304. Struthers A D (2000) The diagnosis of heart failure. Heart 84 (3), pp. 334-338.
305. Subramanian U, Weiner M, Gradus P, Jingwel W and Murray M D (2005) Patient perception and provider assessment of severity of heart failure as predictors of hospitalisation. Heart and Lung 34 (2), pp. 89-98.
306. Sullivan M J, Higginbottom M B and Cobb F R (1989) Exercise training in patients with chronic heart failure delays ventricular aerobic threshold and improves submaximal exercise performance. Circulation 79 (2), pp. 324-329.
307. Summers R L, Peacock W F, Vogel J and Emerman C E (2006) Impact of impedance cardiography on diagnosis and therapy of emergent dyspnea: the ED-IMPACT trial. Academic Emergency Medicine 13 (4), pp. 365-371.
308. Suskin N, Sheth T, Negassa A and Yusuf S (2001) Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. Journal of the American College of Cardiology 37 (6), pp. 1677-1682.
309. Swedberg K, Kjekshus J and Snapinn S (1999) Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I. European Heart Journal 20 (2), pp. 136-139.
310. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M et al. (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary. European Heart Journal 26 (11), pp. 1115-1140.
311. Tenenbaum A, Freimark D, Ahron E, Koren M N, Schwamenthal E, Fisman E Z et al. (2006) Long-term versus intermediate-term supervised exercise training in advanced heart failure: effects on exercise tolerance and mortality. International Journal of Cardiology 113 (3), pp. 364-370.
312. Teragaki M, Takeuchi K and Takeda T (1993) Clinical and histologic features of alcohol drinkers with congestive heart failure. American Heart Journal 125 (3), pp. 808-817.
313. The AIRE Study Investigators (1993) Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Lancet 342 (8875), pp. 821-828.
314. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The New England Journal of Medicine 337 (22), pp. 1576-1583.
315. The Australia-New Zealand Heart Failure Research Collaborative Group (1995) Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation 92 (2), pp. 212-218.
316. The CIBIS-II Investigators (1999) The cardiac insufficiency bisoprolol study II (CIBIS-II):a randomised trial. The Lancet 353 (9146), pp. 9-13.
317. The HOPE Study Investigators (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The New England Journal of Medicine 342 (3), pp. 145-153.
318. The MERIT-HF Investigators (1999) Effects of metoprolol CR/XL in chronic heart failure:metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). The Lancet 353 (9169), pp. 2001-2007.
319. The RALES Investigators (1996) Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study (RALES)). The American Journal of Cardiology 78 (8), pp. 902-7.
320. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The New England Journal of Medicine 325 (5), pp. 293-302.
321. The SUPPORT Principal Investigators (1995) A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The Journal of the American Medical Association 274 (20), pp. 1591-1598.
322. The United Kingdom Prospective Diabetic Study Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet 352 (9131), pp. 854-865.
323. Thomas K L and Velazquez E J (2005) Therapies to prevent heart failure post-myocardial infarction. Current Heart Failure Reports 2 (4), pp. 174-182.
324. Thompson D R, Bowman G S, Kitson A L, de Bono D P and Hopkins A (1997) Cardiac rehabilitation services in England and Wales: a national survey. International Journal of Cardiology 59 (3), pp. 299-304.
325. Thompson D R, Rosebuck A and Stewart S (2005) Effects of a nurse-led, clinic and home-based intervention on recurrent hospital use in chronic heart failure. European Journal of Heart Failure 7 (3), pp. 377-384.
326. Uretsky B F, Young J B, Shahidi F E, Yellen L G, Harrison M C and Jolly M K (1993) Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. Journal of the American College of Cardiology 22 (4), pp. 955-962.
327. UK Transplant (2007) http://www.uktransplant.org.uk/ukt/statistics/statistics.jsp Van Jaarsveld C H M, Ranchor A V, Kempen G I J M, Coyne J C, Van Veldhuisem D J and Sanderman R (2006) Epidemiology of heart failure in a community-based study of subjects aged > or = 57 years: incidence and long-term survival. European Journal of Heart Failure 8 (1), pp. 23-30.
328. Veinot J P and Johnston B (1998) Cardiac sarcoidosis-an occult cause of sudden death:a case report and literature review. Journal of Forensic Sciences 43 (3), pp. 715-717.
329. Ventura H O and Mehra M R (2005) Bloodletting as a cure for dropsy: heart failure down the ages. Journal of Cardiac Failure 11 (4), pp. 247-252.
330. Visser L and Purday J (1998) Management of cardiogenic shock in a district general hospital. Care of the Critically Ill 14 (7), pp. 240-244.
331. Volpe M, Tritto C and DeLuca N (1993) Abnormalities of sodium handling and of cardiovascular adaptations during high salt intake in patients with mild heart failure. Circulation 88 (4 part 1), pp. 1620-1627.
332. Waagstein F, Bristow M R, Swedberg K, Camerini F, Fowler M B, Silver M A, et al. (1993) Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. The Lancet 342 (8885), pp. 1441-1446.
333. Walsh C R and Levy D (2003) Alcohol and congestive cardiac failure. Letter. Annals of Internal Medicine 138 (1), pp. 75-6.
334. Wang R Y, Alterman A I, Searless J S and MacLellan A T (1990) Alcohol abuse in patients with dilated cardiomyopathy. Archives of Internal Medicine 150 (5), pp. 1079-1082.
335. Watson R D S, Gibbs C R and Lipp G Y A (2000) ABC of heart failure: clinical features and complications. British Medical Journal 320 (7229), pp. 236-239.
336. Widimsky P, Penicka M, Lang O, Kozak T, Motovska Z, Jirmar R and Aschermann M (2006) Intracoronary transplantation of bone marrow stem cells: background, techniques, and limitations. European Heart Journal 8 Supplement, H16-22.
337. Williams B, Poulter N R, Brown M J, Davis M, McInnes G T, Potter J P et al. (2004) The BHS Guidelines Working Party Guidelines for Management of Hypertension: Report of the Fourth Working Party of the British Hypertension Society. Journal of Human Hypertension 18 (3), pp. 139-185.
338. Williams N (2003) Nurse led transitional care improved health related quality of life and reduced emergency department use for heart failure. Evidence-Based Nursing 6 (1), p. 21.
339. Winkens, R and Dinant, G-J (2002) Rational, cost effective use of investigations in clinical practice. British Medical Journal 324 (7340), pp. 783-785.
340. Witham M D, Gillespie N D and Struthers A D (2004) Age is not a significant risk factor for failed trial of beta-blocker therapy in older patients with chronic heart failure. Age and Aging 33 (5), pp. 467-472.
341. Wolk R, Gami A S, Garcia-Touchard A and Somers V K (2005) Sleep and cardiovascular disease. Current Problems in Cardiology 30 (12), pp. 625-662.
342. Wong B and Rattery M P (2006) Use of digoxin in the treatment of chronic heart failure. Progress in Cardiovascular Nursing 21 (3), pp. 158-161.
343. World Health Organization (1980) Report of the WHO/ISFC Task Force on the Definitions and Classifications of Cardiomyopathies. British Heart Journal 44 (6), pp. 672-673.
344. Yao G, Freemantle N, Calvert M J, Stirling B, Daubert J C and Cleland J G F (2007) The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. European Heart Journal 28 (1), pp. 42-51.
345. Young J B, Abraham W T, Smith A L, Leon A R, Liberman R, Wilkoff B et al. (2003) Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. The Journal of the American Medical Association 289 (20), pp. 2685-2694.
346. Ypenburg C, Bax J J, van der Wall E E, Schalij M J and van Eryen I (2007) Intrathoracic impedance monitoring to predict decompensated heart failure. American Journal of Cardiology 99 (4), pp. 554-557.
347. Yu D S, Thompson D R and Lee D T (2005) Disease management programmes for older people with heart failure: crucial characteristics which improve post discharge outcomes. European Heart Journal 27 (9), pp. 596-612.
348. Yusuf S, Pfeffer M A, Swedberg K, Granger C B, Held P, McMurray J J V et al (2003) Effects of candesartan in patients with chronic heart failure and preserved left ventricular ejection fraction: the CHARM-Preserved Trial. The Lancet 362 (9386), pp. 777-781.
349. Zannad F, Briancon S, Juilliere Y, Mertes P-M, Villemot J-P, Alla F, et al. (1999) Incidence, clinical and etiologic features, and outcomes of advanced heart failure: the EPICAL study. Journal of the American College of Cardiology 33 (3), pp. 734-42.